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Introduction
Microtubules are highly versatile filaments formed by polymer-
ization of the protein tubulin in the presence of GTP. In living 
cells the nucleation, polymerization, and depolymerization of 
microtubules is tightly controlled by a large number of specific 
protein complexes (Desai and Mitchison, 1997; Akhmanova 
and Steinmetz, 2008, 2010; Howard and Hyman, 2009). These 
factors are required to produce microtubule structures at the 
correct time, and with the correct mechanical properties and 
organization. This allows microtubules to carry out many diverse 
functions in dividing and nondividing cells. One of the most 
striking roles for microtubules is as part of the mitotic and ana-
phase spindle apparatus required for chromosome segregation 
and controlling the position of the cell division plane during 
cytokinesis (Wittmann et al., 2001). Formation of the anaphase 
central spindle requires the concerted action of a group of 
microtubule-associated proteins and kinesin motors (Eggert et al., 
2006; Glotzer, 2009). Anaphase central spindle formation is 
controlled by a simple mechanism involving an anti-parallel 
microtubule-bundling factor PRC1 and the kinesin KIF4A, which 
suppresses microtubule dynamic instability (Bringmann et al., 
2004; Kurasawa et al., 2004; Lee and Kim, 2004; Zhu and Jiang, 
2005; Zhu et al., 2005; Gruneberg et al., 2006; Bieling et al., 2010; 
Ozlü et al., 2010; Subramanian et al., 2010; Hu et al., 2011). 
Previous studies have suggested that PRC1 is inhibited until the 
onset of anaphase by Cdk1–cyclin B phosphorylation, and this 
is a major factor delaying central spindle formation until the 
onset of anaphase (Jiang et al., 1998; Mollinari et al., 2002; Zhu 
et al., 2006; Neef et al., 2007). The idea that Cdk1 is the key 
negative regulator of central spindle formation has been ques-
tioned by a study indicating that PRC1 may be negatively regu-
lated by Polo-like kinase 1 (Plk1; Hu et al., 2012). However, 
this would be inconsistent with a large body of literature showing 
that Plk1 activity is needed to promote initiation of cytokinesis 
in early anaphase (Niiya et al., 2006; Petronczki et al., 2007; 
Wolfe et al., 2009), and then plays a subsequent role in abscis-
sion timing (Fabbro et al., 2005; Bastos and Barr, 2010).
In addition to control by PRC1, the centralspindlin com-
plex comprised of the MKlp1/KIF23 kinesin-like motor protein 
and the Cyk-4/MgcRacGAP Rho-family GTPase regulator is 
important for central spindle integrity (Mishima et al., 2002). 
Anaphase central spindle formation is controlled by the microtubule-stabilizing factor PRC1 and the kinesin KIF4A. We show that an MKlp2- 
dependent pool of Aurora B at the central spindle, rather 
than global Aurora B activity, regulates KIF4A accumu-
lation at the central spindle. KIF4A phosphorylation by 
Aurora B stimulates the maximal microtubule-dependent 
ATPase activity of KIF4A and promotes its interaction with 
PRC1. In the presence of phosphorylated KIF4A, micro-
tubules grew more slowly and showed long pauses in growth, 
resulting in the generation of shorter PRC1-stabilized 
microtubule overlaps in vitro. Cells expressing only mutant 
forms of KIF4A lacking the Aurora B phosphorylation site 
overextended the anaphase central spindle, demonstrat-
ing that this regulation is crucial for microtubule length 
control in vivo. Aurora B therefore ensures that suppres-
sion of microtubule dynamic instability by KIF4A is restricted 
to a specific subset of microtubules and thereby contributes 
to central spindle size control in anaphase.
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Local regulation of KIF4A by the central 
spindle pool of Aurora B
It has previously been shown that formation of a localized pool of 
Aurora B activity at the central spindle in anaphase requires the ki-
nesin motor protein MKlp2 (Gruneberg et al., 2004; Hümmer and 
Mayer, 2009; Lee et al., 2010; Vázquez-Novelle and Petronczki, 
2010). The formation of this pool of Aurora B is required for the 
phosphorylation of the Aurora B substrate MKlp1 at the central 
spindle (Neef et al., 2006). To test if this mechanism is also impor-
tant for KIF4A targeting in anaphase, cell lines stably expressing 
eGFP-tagged KIF4A and mCherry-PRC1 were produced. Because 
it is difficult to study the events of early anaphase in fixed samples 
due to the short time of anaphase, 11 min in HeLa cells (Bastos 
and Barr, 2010), live-cell imaging was used to study the behavior 
of KIF4A and PRC1. First, cells entering anaphase were treated 
with the specific Aurora B inhibitor ZM447439 or a DMSO sol-
vent control. In control cells KIF4A accumulated on the central 
spindle region 4–5 min after anaphase onset, 2 min after PRC1, 
which is present from 1–2 min (Fig. S1 A and Fig. 2 A). By con-
trast, Aurora B inhibition prevented recruitment of KIF4A to the 
central spindle, but, importantly, did not prevent PRC1 from target-
ing to the central spindle region (Fig. 2 B). Cells were then depleted 
of MKlp2 to specifically interfere with the activity of the central 
spindle pool of Aurora B (Gruneberg et al., 2004; Hümmer and 
Mayer, 2009; Lee et al., 2010; Vázquez-Novelle and Petronczki, 
2010). Consistent with the effects of Aurora B inhibition using 
ZM447439, MKlp2 depletion resulted in retention of KIF4A on 
chromatin and the loss of the central spindle pool (Fig. 2 B and 
Fig. S1 B). After 12 min of anaphase a small amount of KIF4A 
was visible on the central spindle region (Fig. 2 B), possibly reflect-
ing the activity of the delocalized pool of Aurora B in these cells. 
Depletion of PRC1 also resulted in a loss of KIF4A from the cen-
tral spindle but not from the chromatin as cells progress into ana-
phase (Fig. 2 B and Fig. S1 B), consistent with the idea it is a major 
KIF4A binding partner in anaphase (Fig. 1, A and B; Kurasawa 
et al., 2004; Zhu and Jiang, 2005).
To further support the idea that Aurora B regulates KIF4A, 
the timing of Aurora B recruitment to the central spindle was 
investigated. Cell lines stably expressing eGFP-tagged Aurora B 
were imaged as they passed into anaphase. This showed that 
Aurora B is initially retained on the centromeres for the first 
2 min of anaphase, and then transitions to the central spindle 
after 4 min (Fig. 2 C). As expected, depletion of MKlp2 pre-
vented the central spindle recruitment of Aurora B (Fig. 2 C and 
Fig. S1 C). Therefore, Aurora B and KIF4A are recruited to the 
central spindle at a similar time in anaphase, and share the same 
dependency for MKlp2. Inhibition of Aurora B using ZM447439 
did not prevent Aurora B localization in anaphase (Fig. 2 C), pro-
viding further support for the view that Aurora B kinase activity 
rather than some other property is required for KIF4A regulation.
Together, these findings suggest that Aurora B rather than 
Plk1 is the key regulator of KIF4A targeting in anaphase. They 
also reveal a specific requirement for MKlp2 in this process. 
Because MKlp2 depletion does not affect the localization of 
Aurora B to centromeres, this indicates that the central spindle 
pool of Aurora B rather than its global activity regulates the timing 
of KIF4A recruitment.
Again, centralspindlin action is inhibited until the onset of 
anaphase by Cdk1–cyclin B phosphorylation (Mishima et al., 
2004). MKlp1 is required for the bundling of anti-parallel 
microtubule overlaps, and this activity is promoted by Aurora B 
phosphorylation and binding of the 14-3-3 adaptor proteins 
(Mishima et al., 2002; Guse et al., 2005; Neef et al., 2006; 
Pavicic-Kaltenbrunner et al., 2007; Douglas et al., 2010). Aurora 
B localization to the central spindle is under the control of a sec-
ond mitotic kinesin, MKlp2 (Gruneberg et al., 2004). This path-
way creates a restricted pool of Aurora B activity on the central 
spindle specifically in anaphase cells (Fuller et al., 2008). In the 
absence of MKlp2 this Aurora B pool is lost and MKlp1 com-
plexes fail to become phosphorylated, ultimately resulting in the 
failure of cytokinesis (Neef et al., 2006). In turn, the MAD2 spin-
dle checkpoint pathway and Cdk1–cyclin B negatively regulate 
MKlp2 and the relocation of Aurora B to the central spindle, re-
spectively (Hümmer and Mayer, 2009; Lee et al., 2010; Vázquez-
Novelle and Petronczki, 2010). Together these regulatory events 
prevent the activity of central spindle factors before the onset of 
anaphase, and ensure that this structure forms at the right time 
and place. However, despite the central importance of KIF4A in 
anaphase spindle function, it remains unclear how its activity is 
controlled. Here we have investigated how the KIF4A–PRC1 
system is regulated, focusing on the relationship between the key 
mitotic kinase Aurora B and KIF4A function.
Results
Association of KIF4A with the central 
spindle is Aurora B dependent
To analyze how the activities of KIF4A and PRC1 are regu-
lated on the central spindle, PRC1 complexes were isolated from 
cells at different times in anaphase. Western blotting of these 
complexes revealed that PRC1 was phosphorylated by Cdk1 
in metaphase samples on threonine 481 (pT481) and was then 
rapidly dephosphorylated as cells progress through anaphase 
(Fig. 1 A). Concurrently, PRC1 became phosphorylated on 
threonine 602 (pT602) and Plk1 accumulated in the complexes, 
reaching a maximum at 30–60 min (Fig. 1 A). KIF4A, like Plk1, 
was absent from metaphase PRC1 and then progressively accu-
mulated throughout anaphase (Fig. 1 A). Mass spectrometry 
confirmed that KIF4A and Plk1 complexes accumulated as cells 
progressed from early to late anaphase (Fig. 1 B). This suggested 
that Plk1 activity might regulate the assembly of the KIF4A–
PRC1 complex at the central spindle. To test this idea, cells were 
treated with kinase inhibitors specific for Cdk1, Plk1, and 
Aurora B. Surprisingly, Plk1 inhibition using BI2536 did not 
prevent PRC1 and KIF4A localization to the central spindle, 
although in some cells later in anaphase the staining pattern was 
fragmented into discrete punctae rather than the highly ordered 
structure seen in control cells (Fig. 1 C). By contrast, inhibi-
tion of Aurora B with ZM447439 resulted in the loss of KIF4A 
staining at the central spindle (Fig. 1 C). Treatment with the 
Cdk1 inhibitor flavopiridol had little effect on PRC1 or KIF4A 
staining, but did cause some defects in chromosome segrega-
tion (Fig. 1 C). These findings suggested that Aurora B rather 
than Plk1 regulates KIF4A localization in anaphase.
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KIF4A pT799 staining was lost after inhibition of Aurora B, but 
not Plk1 or Cdk1 (Fig. S2 A). Depletion of MKlp2, which 
disregulates the central spindle pool of Aurora B, also resulted 
in a loss of pT799 staining (Fig. S2 B). Together, these results 
demonstrate that Aurora B phosphorylates the pool of KIF4A at 
the central spindle on threonine 799.
Phosphorylation-defective mutants of 
KIF4A fail to support normal central 
spindle length control
To investigate the role of threonine 799 phosphorylation in KIF4A 
targeting and function, cells stably expressing inducible eGFP-
KIF4A or a KIF4T799A/S801A Aurora site mutant were created. 
These cells were then depleted of the endogenous KIF4A using 
siRNA directed to the 3-UTR of the KIF4A mRNA or treated 
with a control siRNA. Replacement of the endogenous KIF4A 
with a wild-type GFP-tagged copy of KIF4A resulted in the 
expected pattern of localization to chromatin and central spindle 
(Fig. 4 A). Strikingly, the KIF4AT799A/S801A Aurora site mutant 
failed to target to the central spindle microtubules in anaphase 
cells (Fig. 4 A). Central spindle length in cells expressing the 
KIF4AT799A/S801A mutant was 14.5 ± 1.8 µm on average, compared 
with 10.6 ± 1.0 µm in cells expressing wild-type KIF4A (Fig. 4 B). 
Aurora B phosphorylates KIF4A at a 
conserved site
Aurora kinases predominantly phosphorylate a consensus 
sequence defined by a cluster of arginine and lysine residues fol-
lowed by a patch of serine or threonine residues (Alexander 
et al., 2011; Kettenbach et al., 2011). Visual inspection of the 
vertebrate KIF4A sequences revealed the presence of a single 
such conserved sequence, RRRTFS, centered on threonine 799 
and serine 801 in human KIF4A (Fig. 3 A). The KIF4A T799A/
S801A Aurora site mutant showed strongly reduced levels of 
phosphorylation in vitro (Fig. 3 A), and specific phosphopep-
tide antibodies (pT799) were therefore raised against this site. 
Western blotting showed that the pT799 epitope was present on 
KIF4A complexes isolated from mitotic but not interphase cell 
populations (Fig. 3 B). In vitro kinase assays using recombinant 
full-length KIF4A showed that Aurora B phosphorylated KIF4A 
and created the pT799 epitope (Fig. 3 C). Furthermore, affinity-
purified pT799 antibodies stained the central spindle in ana-
phase, and spindle poles in metaphase cells (Fig. 3 D). However, 
only the central spindle staining was lost after the depletion of 
Aurora B or KIF4A (Fig. 3 D), suggesting the spindle pole 
staining is not due to KIF4A. To provide evidence this staining 
requires Aurora B activity, specific kinase inhibitors were used. 
Figure 1. Control of PRC1–KIF4A complexes by mitotic kinases. (A) PRC1 complexes were immunoprecipitated using specific antibodies from synchro-
nized HeLa cells entering anaphase, at the time points indicated in the figure. Species-matched GST antibodies were used as a negative control (Control). 
The input and immunoprecipitated fractions (IPs) were analyzed by Western blotting with the antibodies shown in the figure, and (B) mass spectrometry. 
(C) Thymidine-synchronized HeLa cells were treated 8 h after the thymidine washout step for 5 min with DMSO, 1 µM BI2536, 5 µM flavopiridol, or 1 µM 
ZM447439. These cells were fixed, and then stained for DNA with DAPI, rabbit anti-PRC1, and sheep anti-KIF4A. Bar, 10 µm.
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Figure 2. The MKlp2–Aurora B pathway is required for KIF4A targeting to the central spindle in anaphase. (A) HeLa cells stably expressing eGFP-
KIF4A and mCherry-PRC1 were treated with DMSO (control) or 1 µM ZM447439, then imaged every 30 s with a spinning disk confocal microscope. 
Maximum intensity–projected images of the merged eGFP and mCherry channels and a single brightfield image collected at the center plane of the 
image stack are shown. All times are relative to the drug addition (t = 0). A kymograph of the central spindle area is depicted. (B) HeLa cells stably 
expressing eGFP-KIF4A were treated with control, MKlp2, or PRC1 siRNA duplexes for 48 h, and then imaged every minute with a spinning disk 
confocal microscope. Maximum intensity–projected images of eGFP fluorescence are shown at the time indicated. (C) HeLa cells stably expressing 
eGFP–Aurora B were treated with control or MKlp2 siRNA duplexes for 48 h, and then imaged every minute with a spinning disk confocal microscope. 
Control cells were treated with 1 µM ZM447439 as indicated in the figure. Maximum intensity–projected images of eGFP fluorescence are shown at 
the time indicated. Bars, 10 µm.
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Regulation of the KIF4A–PRC1 interaction 
by Aurora B
To identify how Aurora B might regulate KIF4A, PRC1 com-
plexes were isolated from synchronized cells treated with Aurora 
B or Plk1 inhibitors (Fig. 5 A). In control samples, KIF4A and 
Plk1 showed the expected pattern of behavior (Fig. 5, A–C), and 
bound to PRC1 only once cells had entered anaphase (Kurasawa 
et al., 2004; Neef et al., 2007; Santamaria et al., 2007). Western 
blotting revealed that the level of KIF4A in PRC1 complexes 
isolated from cells treated with the Aurora B inhibitor ZM447439 
This compared with 9.1 ± 1.1 µm in cells treated with control 
siRNA that expressed endogenous KIF4A, or 15.33 ± 1.5 µm in 
cells depleted of KIF4A but not rescued by induction of the trans-
gene (4 independent experiments, >30 cells per experiment). 
Quantitation also revealed that the overlap region defined by PRC1 
staining was extended in cells expressing the KIF4AT799A/S801A 
Aurora site mutant (Fig. 4 C). These highly penetrant pheno-
types therefore support the view that phosphorylation of KIF4A 
at threonine 799 by Aurora B is crucial for its localization and 
function in controlling anaphase central spindle length.
Figure 3. KIF4A phosphorylation by Aurora B at 
T799. (A) A schematic depicting the position of the 
kinesin motor domain and central coiled-coil region 
of human KIF4A is shown at the top of the figure. 
A multiple sequence alignment shows the conserved 
Aurora phosphorylation consensus motif, compris-
ing a patch of basic amino acids, in this case ar-
ginine, followed by serine or threonine residues at 
T799 and S801, which are predicted to be phos-
phorylated. In vitro kinase assays were performed 
using full-length wild-type KIF4A or KIF4A T799A/
S801A mutant in the presence and absence of 
50 ng Aurora kinase, 1 mM ATP, and 5 µCi -[32P]ATP 
per reaction. (B) KIF4A was isolated from asynchro-
nous (Interphase) populations of HeLa cells, or cells 
released from a nocodazole block for 30 min. The 
input and immunoprecipitated fractions (IPs) were 
analyzed by Western blotting for KIF4A and KIF4A 
pT799. (C) In vitro kinase assays were performed 
using 1 µg full-length KIF4A or a buffer control in 
the presence and absence of 50 ng Aurora kinase, 
1 mM ATP, and 5 µCi -[32P]ATP per reaction. 
(D) HeLa cells treated with control, Aurora B, and 
KIF4A siRNA duplexes for 48 h were fixed, and then 
stained for DNA with DAPI, mouse anti–Aurora B 
or mouse anti-tubulin, and rabbit anti-KIF4A pT799. 
Bars, 10 µm.
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and that this activity is directed toward anti-parallel microtubule 
overlaps created by PRC1 (Bieling et al., 2010; Subramanian 
et al., 2010). The potent microtubule-stabilizing action of KIF4A 
implies the need for regulation to restrict its function to the ana-
phase central spindle. However, these previous studies do not 
prove that PRC1 is the sole determinant limiting KIF4A activity 
to the central spindle. The data presented here suggest that 
Aurora B also helps restrict KIF4A activity to the central spindle. 
To investigate the roles of PRC1 and Aurora B in regulating the 
microtubule binding of KIF4A, purified recombinant PRC1 and 
KIF4A were therefore tested in microtubule-binding assays. 
Earlier work has shown that PRC1 is inhibited until the onset of 
anaphase by Cdk1–cyclin B phosphorylation (Mollinari et al., 
2002; Neef et al., 2007), and this was therefore used as a con-
trol. As expected, PRC1 pelleted with microtubules and this was 
reduced for the Cdk1-phosphorylated form (Fig. 6 A). However, 
little difference was seen in the pelleting behavior of nonphos-
phorylated and threonine 799 Aurora-phosphorylated forms 
of full-length KIF4A in either the absence or presence of PRC1 
(Fig. 6 A). Similarly, the KIF4A motor domain lacking the 
Aurora phosphorylation site bound directly to microtubules in 
a PRC1- and Aurora-independent fashion (Fig. 6 B). PRC1, 
KIF4A, and KIF4A motor domain pelleting was dependent on 
was reduced to 40% of the control value (Fig. 5, A and B), suggest-
ing that Aurora B promotes the interaction between PRC1 and 
KIF4A. Plk1 inhibition with BI2536 had no effect on the amount 
of KIF4A present in PRC1 complexes (Fig. 5, A and B). By con-
trast, Plk1 interaction with PRC1 was lost and PRC1 phosphory-
lation at threonine 602 reduced in the samples treated with the Plk1 
inhibitor BI2536 (Fig. 5, A and C), as published previously (Neef 
et al., 2007; Santamaria et al., 2007; Bastos and Barr, 2010). In-
vestigation of KIF4A turnover at the central spindle using 
FRAP revealed that it had a short half-life in the range of 4–5 s 
at this structure, similar to the half-life on metaphase chromatin 
(Fig. 5 D). Inhibition of Aurora B immediately before bleaching 
reduced the recovery of KIF4A at the central spindle (Fig. 5 D). 
Aurora B is therefore required to maintain a highly dynamic pool 
of KIF4A at the central spindle. In part, this is by promoting the 
interaction with PRC1; however, this does not exclude further 
regulation of microtubule-binding and kinesin ATPase activities, 
and these possibilities were investigated further.
KIF4A ATPase activity is increased by 
Aurora B phosphorylation
Previous studies have demonstrated that the Xenopus KIF4A 
orthologue XKlp1 has potent microtubule-stabilizing activity, 
Figure 4. KIF4A phosphorylation at T799 regulates central spindle length. (A) HeLa cells stably expressing doxycycline-inducible eGFP-tagged KIF4A 
wild-type and KIF4AT799A/S801A Aurora site double mutants were treated with control or KIF4A-3UTR siRNA duplexes for 24 h, then 1 µg/ml doxycycline 
was added. After a further 24 h the cells were fixed, and then stained for DNA with DAPI, mouse anti-tubulin (red), rabbit anti-PRC1 (red), and KIF4A-
eGFP constructs (green). Bar, 10 µm. Equivalent samples were taken for Western blotting as shown in the figure to confirm KIF4A depletion and induction 
of eGFP-KIF4A. (B) Anaphase central spindle length and (C) the ability of PRC1 to focus on the overlapped region of the central spindle were measured. 
The values are plotted on the bar graphs for 4 independent experiments measuring >30 cells per experiment. Error bars show the standard deviation from 
the mean.
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alone was not sensitive to phosphorylation and showed high activ-
ity under all conditions tested (Fig. 6 E). Furthermore, the addition 
of PRC1 to assays performed using full-length phosphorylated 
and nonphosphorylated forms of KIF4A made no difference to 
the ATPase activity (Fig. 6 F). To confirm the effect of Aurora B 
was mediated by phosphorylation at the conserved T799/S801 
site, this was mutated to alanine and recombinant protein tested 
in kinesin ATPase assays. As expected, wild-type KIF4A showed 
Aurora B stimulated ATPase activity prevented by inhibition of 
Aurora B using the specific inhibitor ZM447439 (Fig. 6 G). In 
contrast, the KIF4AT799/S801A mutant did not show Aurora B stim-
ulation of ATPase activity (Fig. 6 H). Importantly, both wild-
type KIF4A and the KIF4AT799/S801A mutant showed the same 
basal level of microtubule-stimulated ATPase activity before 
Aurora phosphorylation (Fig. 6, G and H).
the presence of microtubules, indicating they were not precipi-
tating under these conditions (Fig. S3 A). Titration of phosphory-
lated and nonphosphorylated KIF4A over a wide range of 
concentrations also failed to reveal any alteration in microtubule 
binding (Fig. S3 B). The purified proteins used for these assays 
are shown in Fig. 6 C.
The possibility that Aurora B phosphorylation promotes 
KIF4A motor activity was therefore tested using microtubule-
stimulated ATPase assays. In the absence of microtubules, the 
ATPase activity of KIF4A was the same as ATP incubated in 
buffer alone. In the presence of microtubules, full-length KIF4A 
incubated with buffer or inactive kinase showed similar ATPase 
activities, whereas threonine 799 phosphorylated KIF4A had an 
ATPase activity nearly fourfold higher (Fig. 6 D). This effect 
was specific for the full-length motor because the motor domain 
Figure 5. Aurora B regulates the interaction of KIF4A and PRC1. (A) PRC1 complexes were immunoprecipitated using specific antibodies from synchro-
nized HeLa cells entering anaphase treated with DMSO, 1 µM ZM447439, or 1 µM BI2536 at the time points indicated in the figure. Matched GST 
antibodies were used as a negative control (Control). The input and immunoprecipitated fractions (IPs) were analyzed by Western blotting with the antibod-
ies shown in the figure. (B) The amount of PRC1-associated KIF4A and (C) Plk1 was measured using densitometry in ImageJ and is plotted in the graphs 
(n = 3). (D) FRAP analysis of eGFP-KIF4A. Fluorescence images of FRAP processes for eGFP-KIF4A for either metaphase chromatin or anaphase central 
spindle associated are shown. The square dashed line indicates areas of bleaching where fluorescence recovery was measured. Bar, 10 µm. Fluorescence 
recovery (fluorescence/prebleach fluorescence, F/F0) as a function of time for metaphase (green, n = 3), anaphase (red, n = 7), and ZM447439 treated 
(blue) is plotted.
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controlling both the interaction of KIF4A with PRC1 and its 
kinesin ATPase activity. Furthermore, this stimulation of ATPase 
activity is a direct consequence of Aurora B phosphorylation at 
T799/S801, and does not require the interaction with PRC1.
Phosphorylated KIF4A reduces growth of 
PRC1-microtubule overlaps
Anti-parallel microtubule overlaps were created in vitro using 
PRC1 and purified tubulin as described previously (Bieling 
et al., 2010). Imaging revealed that these PRC1–microtubule 
overlaps extended linearly to reach a mean length of 16 µm, 
and addition of KIF4A reduced this overlap length to 8–9 µm 
during the 5-min incubation period (Fig. 7, A and B). When 
ATPase assays were then performed under a range of 
microtubule concentrations to enable calculation of the apparent 
Km for microtubules and the maximal ATPase activity of KIF4A 
(Fig. 6 I). This revealed that phosphorylation did not alter Kapp 
MT, which was 0.2 µM in both cases, consistent with measure-
ments of microtubule-binding activity. Microtubule-stimulated 
ATPase activity was increased from a kcat of 28.2 s1 to 117.3 s1 
when KIF4A was prephosphorylated with Aurora B. In the 
absence of microtubules, ATPase activity was 5,000-fold lower. 
These values fall within the range reported for kinesins with 
high processivity (Friel and Howard, 2012).
Together, these results suggest that phosphorylation 
by Aurora B at the central spindle is a major regulatory event 
Figure 6. Phosphorylation by Aurora B increases KIF4A kinesin ATPase activity. (A) Microtubule-binding assays were performed as described in Materials 
and methods using 10 nM of the full-length KIF4A (KIF4FL), or (B) 33 nM of the KIF4A motor domain (KIF4MD) in the presence or absence of 10 nM PRC1 or 
Cdk1-phosphorylated PRC1 as indicated. Equivalent aliquots of the microtubule pellet fraction (P) and supernatant fractions (S) were analyzed by Western 
blotting. (C) Coomassie blue–stained gels of proteins used in the assays are shown. (D) Kinesin ATPase assays were performed using 50 nM KIF4FL (n = 5 
independent experiments), (E) 75 nM KIF4MD (n = 2 independent experiments), or (F) KIF4FL in the presence or absence of 50 nM PRC1 (n = 2 independent 
experiments). For some conditions, KIF4A was phosphorylated using wild-type active Aurora kinase (AurWT) or an inactive “kinase-dead” mutant (AurKD). 
(G) Kinesin ATPase assays were performed using 50 nM KIF4FL or (H) KIF4S799A/T801A mutant left untreated or phosphorylated using wild-type active Aurora 
kinase (AurWT) in the presence or absence of 10 µM ZM447439 Aurora B inhibitor (n = 3 and n = 2 independent experiments, respectively). (I) Kinesin 
ATPases assays were performed using 50 nM full-length KIF4A or Aurora-phosphorylated KIF4A at different microtubule concentrations in 150 µl final 
volume for n = 2 independent experiments. Initial ATPase rates were plotted as a function of microtubule concentration. Assuming ATPase activity followed 
Michael-Menten kinetics, Kapp and Vmax were obtained.
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presence of PRC1. The effects of Aurora phosphorylation of 
KIF4A were then investigated. For this purpose the concentra-
tion of full-length KIF4A was reduced to 50 nM, a concentra-
tion at which it showed only a moderate effect on microtubule 
polymerization in the presence of 100 nM PRC1 (Fig. 7 D). 
Addition of 50 nM phosphorylated full-length KIF4A reduced 
both the rate and extent of microtubule polymerization, whereas 
KIF4A treated with inactive kinase behaved similarly to the 
untreated full-length motor protein (Fig. 7 D). As a further con-
trol, the effect of phosphorylation on the KIF4A motor domain, 
which lacks the Aurora B phosphorylation site, was tested. As 
expected, the effect of the KIF4A motor domain on microtubule 
Aurora B–phosphorylated KIF4A was used, the PRC1 overlap 
region extended for a short period at the start of the incubation 
and then stalled at a mean length of just under 5 µm.
Recombinant KIF4A motor domain and full-length 
KIF4A were then tested for their effects on microtubule poly-
merization from purified tubulin in solution. Under standard con-
ditions where microtubule polymerization was limiting, 100 nM 
PRC1 promoted microtubule polymerization (Fig. 7 C). Addi-
tion of 100 nM full-length KIF4A reduced both the rate and 
extent of microtubule polymerization to a level that was inter-
mediate to a buffer control or KIF4A alone (Fig. 7 C). Human 
KIF4A can therefore limit microtubule polymerization in the 
Figure 7. Reduced PRC1-microtubule overlap length in the presence of phosphorylated KIF4A. (A) Representative kymographs showing antiparallel 
overlaps formed by microtubules growing from GMP-CPP–stabilized microtubule seeds (green) in the presence of 14 nM mCherry-PRC1, 14 nM mCherry-
PRC1 and 28.5 nM KIF4, or 14 nM mCherry-PRC1 and 28.5 nM KIF4P over 5 min. For the kymographs, t = 0 is when PRC1 localization is first observed, 
indicating establishment of an anti-parallel overlap. The growing overlap length is indicated by dotted lines. Bar, 10 µm. (B) Average length of anti-parallel 
microtubule overlaps in the presence of mCherry-PRC1 (left, n = 9), mCherry-PRC1 and KIF4A (middle, n = 15), or mCherry-PRC1 and KIF4P (middle, 
n = 20) as a function of time. Errors are shown by the dotted lines. Average overlap length after 5 min is plotted with standard error in the bar graph. 
(C) Microtubule polymerization assays were performed using 100 nM of PRC1 and 100 nM of full-length recombinant KIF4A (KIF4FL) for n = 3 independent 
experiments. (D) Full-length recombinant KIF4A was phosphorylated using wild-type active Aurora kinase (AurWT) or an inactive “kinase-dead” mutant (AurKD). 
Microtubule polymerization assays were then performed in the presence of 100 nM PRC1 and 50 nM of each form of KIF4A for n = 4 independent experi-
ments. (E) Recombinant KIF4A motor domain was phosphorylated using wild-type active Aurora kinase (AurWT) or an inactive “kinase-dead” mutant (AurKD). 
Microtubule polymerization assays were then performed using 500 nM recombinant KIF4A motor domain (KIF4MD) in the presence of 100 nM PRC1 for 
n = 3 independent experiments.
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These effects were further increased when 44 nM KIF4A was 
used (Fig. 8, A–C). When taken together, these results support 
the view that KIF4A suppresses microtubule growth (Bieling 
et al., 2010), and demonstrate that this activity is enhanced by 
Aurora B phosphorylation. This provides a mechanism to re-
strict KIF4A activity to anaphase spindle microtubules.
Re-wiring the Aurora B central spindle 
length control system
To further test the idea that phosphorylation at the anaphase 
central spindle is crucial for KIF4A function, the endogenous 
Aurora B targeting system was replaced by a synthetic construct. 
This used a kinase module comprising the activation region of 
INCENP joined to a truncated form of Aurora B (Sessa et al., 
2005), coupled to the microtubule-targeting region of PRC1. 
This Baronase module (B-type Aurora kinase) exhibits high ki-
nase activity toward both a model substrate and KIF4A and is 
sensitive to the Aurora B inhibitor ZM447439 (Fig. S5, A and B). 
A similar module, Aaronase (A-type Aurora kinase) was also 
created and tested and found to be sensitive to an Aurora A 
inhibitor but not used further here (Fig. S5 A). Stable cell lines 
expressing a doxycycline-inducible PRC1-Baronase were then 
created. When depleted of MKlp2 these cells retain Aurora B 
and KIF4A on the chromatin in anaphase, and Aurora B marker 
phosphorylation at MKlp1 pS911 is lost (Fig. 9, A–D). Induction 
polymerization was not altered by treatment with either wild-
type or inactive kinase (Fig. 7 E). KIF4A therefore reduces 
microtubule polymerization in vitro, and this activity is enhanced 
by Aurora B phosphorylation.
One explanation for these effects was that KIF4A has 
an ATP-dependent microtubule-destabilizing activity similar to 
MCAK (Walczak et al., 1996). This was tested using taxol- 
stabilized microtubules as a substrate (Fig. S4). As shown pre-
viously (Walczak et al., 1996, 2002), MCAK was able to 
depolymerize microtubules in an ATP-dependent fashion, and 
this activity was inhibited by Aurora B phosphorylation (Fig. S4, 
A and B) as expected (Andrews et al., 2004; Lan et al., 2004). 
Under the same conditions KIF4A had no effect on microtubule 
stability (Fig. S4, C and D), suggesting it is not an active micro-
tubule-destabilizing kinesin. To further define how KIF4A reduces 
microtubule polymerization, single polymerizing microtubules 
were imaged over a period of 10 min (Fig. 8). In the absence of 
KIF4A, microtubules showed long periods of stable growth 
with only a few short pauses (Fig. 8, A and B). Under these con-
ditions the mean growth rate was 1.3 µm/min (Fig. 8 C). Addi-
tion of 22 nM KIF4A altered this behavior such that the pause 
time increased to 50 s and the mean growth rate was reduced to 
0.75 µm/min (Fig. 8, A–C). Aurora B–phosphorylated 22 nM 
KIF4A resulted in a doubling in the pause time to 100 s and an 
additional reduction in growth rate to 0.6 µm/min (Fig. 8, A–C). 
Figure 8. Suppression of microtubule dynamics by KIF4A is 
enhanced by Aurora B phosphorylation. (A) Kymographs of 
microtubule growth in the absence and presence of KIF4A 
and phosphorylated KIF4A (KIF4P). Microtubule growth was 
frequently interrupted by pauses indicated by green double-
headed arrow. Microtubule growth rate is indicated by dot-
ted triangles. Horizontal bar 10 µm; vertical bar, 0.5 min. 
(B) Average microtubule pause time was measured in the ab-
sence of KIF4A (n = 30), in the presence of 22 nM (n = 42) 
and 44 nM KIF4A (n = 29), and in the presence of 22 nM 
(n = 36) and 44 nM KIF4P (n = 32). (C) Average growth rate 
of microtubule in the absence of KIF4A (n = 36), in the pres-
ence of 22 nM (n = 42) and 44 nM KIF4A (n = 28), and in 
the presence of 22 nM (n = 35) and 44 nM KIF4P (n = 20). 
Error bars represent SEM.
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motors (Hackney, 2007), or by the dual lockdown mechanism 
recently reported for kinesin-1 (Kaan et al., 2011). In both 
cases, phosphorylation of KIF4A in the stalk region might re-
lease auto-inhibition of the kinesin head domains and therefore 
increase activity. This may also be the structural basis for in-
creased affinity to PRC1. However, more detailed analysis of 
the KIF4A ATPase cycle and single molecule measurements 
of movement and processivity will be needed to understand 
the molecular basis of this form of regulation. Although these 
parameters have not been measured here, the kcat of 28.2 s1 for 
nonphosphorylated KIF4A assuming tight coupling of stepping 
to ATP turnover suggests a speed of 0.4 µm/s, consistent with axo-
nemal gliding assays showing in vitro movement of 0.2 µm/s 
(Sekine et al., 1994). The increased ATPase activity seen after 
phosphorylation may therefore reflect increased processivity. This 
would increase the chance that after encountering a micro-
tubule, KIF4A will reach the microtubule plus-end and sup-
press further microtubule growth or shrinkage.
To our knowledge, this is the first description of an acti-
vating role for Aurora B in the spatial and temporal regulation 
of a kinesin-like protein. Previous studies have implicated 
Aurora B in the inhibition of the microtubule-destabilizing 
kinesin-like protein MCAK important for destabilizing incorrect 
microtubule attachments to kinetochores during mitotic and mei-
otic spindle formation (Walczak et al., 1996, 2002; Andrews 
et al., 2004; Lan et al., 2004; Ohi et al., 2004; Tanenbaum et al., 
2011). Interestingly, a recent report indicates that KIF4A may 
work together with MCAK to promote chromosome congres-
sion (Wandke et al., 2012), and our work hints that Aurora B 
may be a factor coordinating the relative activities of these 
two motors. Influential studies on the regulation of the KIF11/
Eg5 motor protein required for centrosome separation during 
spindle formation have shown that Cdk1 phosphorylation at a 
conserved threonine residue is required for its spindle targeting 
and function (Blangy et al., 1995; Sawin and Mitchison, 1995), 
and thereby acts as a temporal control mechanism. Activating 
phosphorylations may therefore be a general mechanism con-
trolling the temporal and spatial activity of kinesin-like motor 
proteins. However, neither in the case of KIF11/Eg5 nor KIF4A 
is this completely understood, and further structural studies will 
be necessary to validate these ideas.
Regulation of central spindle formation  
and size
These results, taken together with previous findings, add to an 
emerging picture of how microtubule function at the central 
spindle is regulated in anaphase (Fig. 10). High Cdk1 and spin-
dle checkpoint activity in metaphase cells is important for inhib-
iting the activity of PRC1 and other components of the central 
spindle (Mollinari et al., 2002; Mishima et al., 2004; Hümmer and 
Mayer, 2009; Lee et al., 2010; Vázquez-Novelle and Petronczki, 
2010). Once the spindle checkpoint is satisfied, Cdk1 activity 
falls and PRC1 can start to organize anti-parallel microtubule 
bundles (Subramanian et al., 2010; Elad et al., 2011). PRC1 will 
therefore fail to promote microtubule organization in metaphase 
cells with high levels of Cdk1–cyclin B activity (Jiang et al., 
1998; Mollinari et al., 2002; Zhu et al., 2006; Neef et al., 2007). 
of PRC1-Baronase rescues MKlp1 pS911 phosphorylation, and 
supports localization of KIF4A to the central spindle and KIF4A 
phosphorylation at threonine 799 (Fig. 9, A–D). Because Baronase 
was engineered to remove the epitope for the AIM1 monoclonal 
antibody, endogenous Aurora B could be detected independently 
of the transgene. This showed that although endogenous Aurora 
B was retained on the chromatin (Fig. 9, A and B), this did not 
interfere with KIF4A function.
This strategy also permits the reconstitution of Aurora B–
decorated microtubule overlap structures in vitro. Anti-parallel 
microtubule overlaps were created in vitro using recombinant 
PRC1-Baronase and purified tubulin. Imaging revealed that these 
PRC1-Baronase microtubule overlaps extended linearly, simi-
larly to those created using PRC1 (Fig. 9 E). Addition of KIF4A 
resulted in slow overlap length to 3 µm during the 5-min incuba-
tion period (Fig. 9, E and F). When Aurora B phosphorylation 
of KIF4A was prevented with ZM447439, the PRC1 overlap 
region extended more rapidly and achieved a mean length of 
6 µm (Fig. 9, E and F). This system therefore recapitulates the 
regulation of KIF4A by a locally targeted pool of Aurora B at 
the microtubule overlap region of the central spindle.
Discussion
Suppression of microtubule dynamic 
instability by KIF4A and Aurora B
Here we have studied how the kinesin KIF4A and the anti- 
parallel microtubule-bundling factor PRC1 are regulated in ana-
phase (Bieling et al., 2010; Subramanian et al., 2010; Hu et al., 
2011). We find that Aurora B directly phosphorylates KIF4A in 
the central coiled-coil stalk region and that this has two conse-
quences. First, it enhances the binding of KIF4A to PRC1, and 
second, it increases the ATPase activity of KIF4A, thereby sup-
pressing microtubule growth. Together, these two changes re-
strict KIF4A to the central spindle in anaphase. In the absence 
of Aurora B activity, KIF4A fails to localize to the central spin-
dle, most likely due to a reduction in its affinity for PRC1. This 
results in an altered balance of microtubule polymerization 
events in this region, and over-extension of the anaphase central 
spindle and increased chromosome segregation. Interestingly, 
the results appear to eliminate a model whereby centromeric/
chromatin Aurora B would promote KIF4A leaving the chroma-
tin because cells depleted of MKlp2 retain both Aurora B and 
KIF4A on the chromatin. This chromatin-bound pool of KIF4A 
has a discrete function in lateral condensation of mitotic chro-
mosomes (Samejima et al., 2012), and may therefore be func-
tionally and spatially separated from the pool of KIF4A involved 
in central spindle formation.
The data presented here also show that PRC1 binding is 
necessary but not sufficient for full targeting and movement of 
KIF4A to the central spindle. This relocation also requires acti-
vation of the kinesin motor activity by Aurora B phosphoryla-
tion. A motor domain fragment lacking the stalk and coiled-coil 
region shows high constitutive ATPase activity unregulated by 
Aurora B. This suggests that full-length KIF4A is in a par-
tially inhibited form perhaps with the head groups bound back 
on to a coiled-coil sequence in the stalk region similar to other 
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Figure 9. Reconstitution of Aurora B phosphorylation on PRC1-stabilized microtubule overlaps in vivo and in vitro. (A) HeLa cells stably expressing doxy-
cycline-inducible eGFP-tagged PRC1-Baronase were treated with control or MKlp2-3UTR siRNA duplexes for 24 h followed by thymidine synchronization 
for 20 h. Cells were washed with media and 1 µg/ml doxycycline (dox.) was either added or omitted. Cells were fixed 9 h after release, and then stained 
for DNA with DAPI, mouse anti–Aurora B, and either rabbit MKLp1 pS911or (B) sheep KIF4A. Bars, 10 µm. (C) Western blotting confirmed MKlp2 deple-
tion and induction of eGFP-PRC1–Baronase construct. In vitro kinase assays were performed using full-length wild-type KIF4A in the absence or presence 
of Baronase kinase with and without ZM447439 treatment, as well as with the mCherry-PRC1–Baronase protein. Samples were analyzed by Western 
blotting for KIF4A and KIF4A pT799. (D) The presence of Aurora B, phosphorylated MKlp1 pS911, and KIF4A on the central spindle was scored. The 
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EMD Millipore). Affinity-purified primary and secondary antibodies were 
used at 1 µg/ml final concentration. Secondary antibodies conjugated 
to HRP were obtained from Jackson ImmunoResearch Laboratories, Inc. 
Secondary antibodies conjugated to Alexa Fluor 488, 555, and 647 were 
obtained from Invitrogen. DNA was stained with DAPI (Sigma-Aldrich).
Kinase inhibitors were obtained from Sigma-Aldrich (flavopiridol 
5 mM, 1,000× stock), Tocris Bioscience (ZM447439 10 mM, 1,000× 
stock), and Axon Medchem (BI2536 1 mM, 1,000× stock). Reagents for 
microtubule polymerization and kinesin ATPase assays were obtained from 
Cytoskeleton, Inc. A benchtop microfuge (5417R; Eppendorf) was used for 
all centrifugations unless otherwise indicated.
Molecular biology
Human MCAK was amplified by PCR from IMAGE clone #3909438 
(Source Bioscience) using KOD polymerase (Takara Bio Inc.). Human 
KIF4A, Aurora A and B, INCENP, TPX2, and PRC1 splice variant 2 
were amplified directly from human testis cDNA as described previ-
ously (Gruneberg et al., 2004; Klein et al., 2006; Neef et al., 2007). The 
KIF4AT799A/S801A phosphorylation site mutant was created using Quik-
Change mutagenesis according to the supplied instructions (Agilent 
Technologies). Mammalian expression constructs for N-terminally tagged 
KIF4A, Aurora B, and PRC1 were made using pcDNA4/TO and pcDNA5/
FRT/TO vectors (Invitrogen) modified to encode the eGFP or mCherry reading 
frames (Bastos and Barr, 2010). The Aaronase and Baronase modules 
were designed from existing crystal structures (Bayliss et al., 2003; Sessa 
et al., 2005) and created using standard molecular biology procedures 
Other factors not shown in the model, including the centralspin-
dlin complex, also contribute to the formation of this anti-parallel 
overlapped structure and the formation of the midbody (Sellitto 
and Kuriyama, 1988; Nislow et al., 1992; Mishima et al., 2002; 
Douglas et al., 2010). KIF4A is then crucial for ensuring that 
these microtubule-stabilizing and -organizing factors are op-
posed, and a microtubule structure of the required size is created 
(Bringmann et al., 2004; Bieling et al., 2010; Hu et al., 2011). 
Here we explain how the activity of KIF4A in suppressing 
microtubule dynamics is restricted to the central spindle by a 
conserved activating phosphorylation at threonine 799 per-
formed by the Aurora B kinase. Aurora B is delivered to the cen-
tral spindle due to the activity of another kinesin-like motor 
protein, MKlp2, a process inhibited before the start of anaphase 
by Cdk1 and the spindle checkpoint machinery (Hümmer and 
Mayer, 2009; Vázquez-Novelle and Petronczki, 2010). Our data 
highlight the importance of the Aurora B chromosomal passen-
ger complex for the correct ordering of events in anaphase after 
Cdk1 inactivation. It has been proposed that relocation of Aurora B 
away from the centromeres primarily ensures the spindle check-
point remains silent upon sister chromatid separation once ten-
sion is lost, a condition that might reactivate the checkpoint if 
Aurora B remained active at the centromeres (Mirchenko and 
Uhlmann, 2010; Vázquez-Novelle and Petronczki, 2010). How-
ever, as shown here, human cell lines with both chromatin and 
central spindle–targeted Aurora B enter anaphase and carry out 
anaphase-specific phosphorylations (Fig. 2 C and Fig. 9, A–D). 
This suggests that the primary reason Aurora B relocates from 
the centromeres at the onset of anaphase is to ensure proper 
regulation of anaphase spindle dynamics by KIF4A and MKlp1 
(Gruneberg et al., 2004; Guse et al., 2005; Fuller et al., 2008; 
Douglas et al., 2010). Together, these findings help explain how 
mitotic kinases and kinesin motor proteins work together in the 
temporal and spatial control of mitosis and cytokinesis.
Materials and methods
Reagents and antibodies
General laboratory chemicals and reagents were obtained from Sigma- 
Aldrich and Thermo Fisher Scientific. Sheep antibodies were raised to 
MKlp1 (aa 1–444), KIF4A (full-length protein expressed in insect cells), 
and MKlp2 (aa 63–193) (Neef et al., 2003, 2007; Bastos and Barr, 
2010). Rabbit antibodies were raised to full-length recombinant PRC1, 
PRC1 pT602 peptide CILNS(pT)NIQS, KIF4A (aa 738–1323), KIF4A (aa 
738–1232), KIF4A pT799 peptide LRRR(pT)FSLT, and MKlp1 pS911 pep-
tide CRKRR(pS)STVA (Neef et al., 2003, 2006, 2007; Gruneberg et al., 
2006). Specific antibodies were purified using the antigens conjugated to 
Affigel-15, eluted with 0.2 M glycine-HCl, pH 2.8, then dialyzed against 
PBS before storage at 80°C. Commercially available antibodies were 
used to -tubulin (mouse DM1A; Sigma-Aldrich), Plk1 (mouse sc-17783; 
Santa Cruz Biotechnology, Inc.), PRC1 pT481 (sc-11768, Santa Cruz 
Biotechnology, Inc.; and EP1514Y, Epitomics, Inc.), the RGS-His tag epit-
ope (QIAGEN), AIM1 (mouse 611083; BD), and cyclin B1 (mouse GNS3; 
values are plotted on the bar graphs for 3 independent experiments measuring >80 cells per experiment. Error bars show the standard deviation from the 
mean. (E) Kymographs show anti-parallel overlaps formed over 5 min by microtubules growing from GMP-CPP–stabilized seeds (green) in the presence of 
14 nM mCherry-PRC1-Baronase, 14 nM mCherry-PRC1-Baronase and 28.5 nM KIF4, or 14 nM mCherry-PRC1-Baronase and 28.5 nM KIF4 with 10 µM 
ZM447439 to inhibit Aurora B kinase activity. For the kymographs, t = 0 is when mCherry-PRC1–Baronase is first observed, indicating establishment of an 
anti-parallel overlap. The growing overlap length is indicated by the dotted line. Bar, 10 µm. (F) Anti-parallel microtubule overlap length of in the presence 
of mCherry-PRC1 and KIF4A (n = 6), and mCherry-PRC1 and KIF4P (n = 8), is plotted as a function of time. Errors are shown by the dotted lines. Average 
overlap length at 5 min is plotted in the bar graph. Error bars show the standard error (n = 8 and n = 9).
 
Figure 10. A model for Aurora B regulation of central spindle size. In 
early anaphase, PRC1 promotes the formation of anti-parallel microtubule 
overlaps at the central spindle. At the same time Aurora B is transported 
to these overlap structures by Mklp2, establishing a local high concen-
tration of Aurora B. Phosphorylated KIF4A (KIF4P) suppresses plus-end 
microtubule dynamics, and thereby limits growth of the central spindle. 
Motor activity of kinesin family proteins depends on its ability to alternate 
between ATP-bound and ADP-bound forms using its ATPase activity. The 
two forms allow kinesins to cycle between high affinity and low affinity to-
ward microtubules, resulting in its movement along microtubules over time 
(Friel and Howard, 2012). The processivity of a motor (number of steps a 
motor takes upon encounter with a microtubule) is directly dependent on 
its ATPase activity (Vmax) as well as its affinity toward microtubules (Kapp 
MT). Phosphorylation of KIF4A by Aurora B increases its ATPase activity 
by 5,000 fold compared with its ATPase activity in the absence of micro-
tubules. However, this increase in ATPase activity is not accompanied by in-
creased affinity toward the microtubules. Alternatively, Aurora B mediated 
phosphorylation may enhance the processivity of KIF4A. Concentration 
of Aurora B activity at the central spindle during anaphase would allow 
increased processivity of KIF4A specifically at the central spindle, allow-
ing the motor to preferentially reach microtubule plus-ends and suppress 
microtubule dynamics in this region.
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inhibitor cocktails [Sigma-Aldrich]), left for 15 min on ice, and then clari-
fied by centrifugation at 20,000 gav for 20 min at 4°C. Protein complexes 
were isolated from 3 mg of cell lysate using 3 µg rabbit antibodies against 
either GST as a matched negative control, or PRC1 bound to 20 µl protein 
A Sepharose by incubation for 2 h at 4°C. Isolated complexes were 
washed once with lysis buffer, then three times with 20 mM Tris-HCl, pH 7.4, 
150 mM NaCl, and 0.1% (vol/vol) IGEPAL. Samples were then analyzed 
by SDS-PAGE and Western blotting.
Mass spectrometry of protein complexes
Protein samples for mass spectrometry were separated on 4–12% gradient 
NuPAGE gels, then stained using a colloidal Coomassie blue stain. Gel 
lanes were cut into 12 slices, and then digested with trypsin (Wilm et al., 
1996). The resulting tryptic peptide mixtures in 0.05% trifluoracetic acid 
were then analyzed by online LC-MS/MS with a nanoAcquity UPLC (Waters) 
and Orbitrap XL ETD mass spectrometer (Thermo Fisher Scientific) fitted 
with a Proxeon nano-electrospray source. Peptides were loaded onto a 
5-cm × 180-µm BEH-C18 Symmetry trap column (part no. 186003514; 
Waters) in 0.1% (volv/vol) formic acid at 15 µl/min, and then resolved 
using a 25-cm × 75-µm BEH-C18 column (part no. 186003815; Waters) 
in 99–37.5% (vol/vol) acetonitrile in 0.1% (vol/vol) formic acid at a flow 
rate of 400 nl/min. The mass spectrometer was set to acquire an MS 
survey scan in the Orbitrap (R = 30,000) and then perform MS/MS on the 
top five ions in the linear quadrupole ion trap after fragmentation using 
collision ionization (30 ms, 35% energy). A 90-s rolling exclusion list with 
n = 3 was used to prevent redundant analysis of the same ions. Maxquant 
and Mascot (Matrix Science) were then used to compile and search the 
raw data against the human IPI database (Cox and Mann, 2008; Cox 
et al., 2009). Protein group and peptide lists were sorted in Excel (Micro-
soft). MS and MS/MS spectra were manually inspected using Xcalibur 
Qualbrowser (Thermo Fisher Scientific).
Fixed- and live-cell microscopy
For fixed-cell imaging samples were prepared and imaged exactly as 
described previously (Bastos et al., 2012). In brief, cells grown on no. 1.5 
glass coverslips (Menzel-Gläser; Thermo Fisher Scientific) were washed 
twice with 2 ml of PBS, and fixed with 2 ml of 3% (wt/vol) paraformalde-
hyde in PBS for 15 min. Fixative was removed and the cells quenched with 
2 ml of 50 mM NH4Cl in PBS for 10 min. Coverslips were washed three 
times in 2 ml PBS before permeabilization in 0.2% (vol/vol) Triton X-100 
for 5 min. In all cases primary and secondary antibody staining was per-
formed in PBS for 60 min at room temperature. Affinity-purified antibodies 
were used at 1 µg/ml, whereas commercial antibodies were used as di-
rected by the manufacturers. DAPI was added to the secondary antibody 
staining solution at 0.3 µg/ml. Coverslips were mounted in Mowiol 4-88 
mounting medium (EMD Millipore). Fixed samples on glass slides were im-
aged using a 60×/NA 1.35 oil immersion objective on an upright micro-
scope (BX61; Olympus) with filtersets for DAPI; GFP/Alexa Fluor 488, 
555, 568, and 647 (Chroma Technology Corp.); a CoolSNAP HQ2 cam-
era (Roper Scientific); and MetaMorph 7.5 imaging software (Molecular 
Dynamics, Inc.). Illumination was provided by a Lumen 200-Watt metal 
halide light source (Prior Scientific Instruments, Ltd). Image stacks of 12–35 
planes with a spacing of 0.2–0.4 µm through the cell volume were taken. 
Image stacks were maximum intensity projected and then merged to create 
24-bit RGB TIFF files in MetaMorph. Images in 24-bit RGB format were then 
cropped in Photoshop CS3 and placed into Illustrator CS3 (Adobe Systems, 
Inc.) to produce the figures.
For live-cell imaging using spinning disk confocal microscopy, cells 
were plated in 35-mm dishes with a 14-mm no. 1.5 thickness coverglass 
window in the bottom (MatTek Corporation). For imaging, the dishes were 
placed in a 37°C and 5% CO2 environment chamber (Tokai Hit) on the 
microscope stage. Imaging was performed at 37°C in 5% CO2 using an 
inverted microscope (IX81; Olympus) with a 60×/1.42 NA oil immersion 
objective coupled to a spinning disk confocal system (Ultraview Vox; Perkin-
Elmer) fitted with an EM-CCD camera (C9100-13; Hamamatsu Photonics). 
Exposure times were 30 ms for GFP-KIF4A, eGFP-Aurora B, and mCherry-
PRC1 using 4% laser power. Image stacks of 24 planes spaced 0.6 µm 
apart were taken at 1–4 stage positions every minute for up to 6 h. A 
brightfield reference image was also taken to visualize cell shape. Maxi-
mum intensity projection of the fluorescent channels was performed in 
Volocity to create 24-bit RGB TIFF files. For FRAP prebleach, 5 image stacks 
of 4 planes with 0.4-µm spacing were acquired at 1-s intervals. Bleach was 
performed using an UltraVIEW PK Device with the 488-nm laser set at 10% 
with the following settings: cycles 5, step size 1, spot period 10, stop period 
10, spot cycles 1, small spot size and no attenuation. Recovery images 
to fuse human INCENP aa 834–897 plus an additional glycine residue 
to the N terminus of Aurora B aa 44–344, or TPX2 aa 1–43 plus an ad-
ditional glycine residue to Aurora A 100–403, creating BamHI–XhoI frag-
ments. These were then ligated into pQE32 for bacterial expression, and 
in the case of Baronase fused to the C terminus of PRC1 for mammalian 
or insect cell expression. Recombinant baculovirus carrying hexahistidine-
tagged full-length PRC1, KIF4A, KIF4AT799A/S801A, MCAK, mCherry-PRC1, 
or mCherry-PRC1-Baronase cloned into the pAcSG2 vector were produced 
using the Baculogold system (Invitrogen). Hexahistidine-tagged bacterial 
expression constructs for the motor domains of KIF4A (aa 1–512) and 
MCAK (aa 1–592) were made in pQE32 (QIAGEN). Mutagenesis was 
performed using the QuikChange method (Agilent Technologies). Primers 
were obtained from Metabion GmbH. The siRNA duplexes used were ob-
tained from Thermo Fisher Scientific or QIAGEN and have been described 
previously (Gruneberg et al., 2006; Neef et al., 2007; Bastos and Barr, 
2010). Target sequences were control 5-CGTACGCGGAATACTTCGA-3, 
PRC1 5-GGCTTCTAGGCGTGAGGAG-3, MKlp2 5-CCACCTATGTA-
ATCTCATG-3, Aurora B 5-CGCGGCACTTCACAATTGA-3, and 5-CAG-
GTCCAGACTACTACTC-3 for the KIF4A 3-UTR.
Human and insect cell culture
HeLa cells were cultured in DMEM containing 10% (vol/vol) bovine calf 
serum (Invitrogen) at 37°C and 5% CO2. For synchronization, cells were 
treated for 18 h with 2 mM thymidine, washed three times in PBS, and 
twice with growth medium. For plasmid transfection and siRNA transfec-
tion, Mirus LT1 (Mirus Bio LLC) and Oligofectamine (Invitrogen), respec-
tively, were used. Stable HeLa cell lines with single copies of the desired 
transgene were created using the T-Rex doxycycline-inducible Flp-In system 
(Invitrogen). Sf-9 insect cells were grown in insect cell growth medium 
(TC100 containing 10% [vol/vol] bovine calf serum and Glutamax [Invitro-
gen]) at 27°C and atmospheric CO2.
Protein expression and purification
Recombinant baculoviruses encoding hexahistidine-tagged KIF4A, 
KIF4AT799A/S801A PRC1, MCAK, mCherry-PRC1, or mCherry-PRC1-Baronase 
were used to infect 4 × 107 insect cells in 20x 15-cm dishes with a multi-
plicity of infection of 10. To infect cells, the medium was removed, and the 
virus added in 3 ml of insect growth medium per dish. Dishes were gently 
rocked for 1 h; every 10 min the dishes were rotated by 90 degrees. After 
1 h, 17 ml insect cell growth medium was added and the cells left for 
60 h before harvesting by centrifugation at 200 g. To obtain M-phase Cdk-
phosphorylated PRC1, the cells were treated for 3 h with 100 nM okadaic 
acid before harvesting. Cell pellets were washed once in ice-cold PBS, and 
then lysed in 10 ml of IMAC20 (20 mM Tris-HCl, pH 8.0, 300 mM NaCl, 
20 mM imidazole, and 0.2% [vol/vol] Triton X-100), and protease inhibi-
tor cocktail (Sigma-Aldrich) for 20 min on ice. A cell lysate was prepared 
by centrifugation at 100,000 g in a TLA100.3 rotor (Beckman Coulter), 
then loaded onto a 1-ml HisTrap FF column (GE Healthcare) at 0.5 ml/min. 
The column was then washed with 30 ml of IMAC20, and eluted with a 
20-ml linear gradient from 20 to 200 mM imidazole in IMAC20 collecting 
1 ml fractions. Peak fractions judged by SDS-PAGE and absorbance at 
280 nm were concentrated using Ultracel-10K centrifugal filters (EMD Mil-
lipore) according to the manufacturer’s instructions to a final volume of 
1 ml. Samples were then buffer exchanged using 5 ml Zeba Desalt Spin 
columns (Perbio) into TND (20 mM Tris-HCl, pH 8, 300 mM NaCl, and 1 mM 
DTT). Protein samples were snap-frozen in 15-µl aliquots and stored at 
80°C for further use. Aurora-phosphorylated proteins were prepared by 
incubating 4 µg purified KIF4A or MCAK with 0.4 µg of Aurora kinase and 
1 mM Mg-ATP for 20 min at 37°C, then kept on ice until required. The 
Aurora B minikinase fusion, and motor domains of KIF4A and MCAK were 
expressed in Escherichia coli strain JM109 and purified in the same way, 
except that cell lysis was performed using an Emulsifex C5 cell breaker 
system (Avestin Europe GmbH).
Protein complex isolation from anaphase cells
Three 15-cm dishes of thymidine-synchronized HeLa S3 cells per condition 
were released for 3 h at 37°C, 100 ng/ml nocodazole added, and incu-
bated further for 12–14 h. Mitotic cells were collected by shake-off and 
nocodazole was removed by washing three times with PBS and twice with 
growth medium warmed to 37°C. At each time point, specified in the figures 
and figure legends, cells were collected and washed three times with ice-
cold PBS. Cell pellets were suspended in mitotic lysis buffer (20 mM 
Tris-HCl, pH 7.4, 150 mM NaCl, 1% [vol/vol] IGEPAL, 0.1% [wt/vol] so-
dium deoxycholate, 40 mM -glycerophosphate, 10 mM NaF, 0.3 mM 
Na-vanadate, 100 nM okadaic acid, and protease and phosphatase 
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TND with 147.5 µl of the microtubule premix at room temperature. To start 
the assay, 10 µl of 10 mM ATP was added to each well. Final assay vol-
ume was 165 µl of 12 mM Pipes-KOH, pH 7, 4 mM MgCl2, 0.61 mM ATP, 
and 14.5 mM NaCl. This was then rapidly transferred to a 37°C plate 
reader (Tristar LB 941; Berthold Technologies) set to read absorbance at 
360 nm. Readings were acquired every 30 s for 1 h. An inorganic phos-
phate standard curve was created in the same assay buffer and used to 
convert absorbance to nmol ATP hydrolyzed.
Dynamic microtubule overlap assays
Porcine brain tubulin was purified and used to produce double-cycled 
GMPCPP-stabilized microtubule seeds using published methods (Castoldi 
and Popov, 2003; Gell et al., 2010). In brief, 10 µl of 2 µM biotin-labeled 
tubulin (Cytoskeleton, Inc.), 2 µM HiLyte-488 tubulin (Cytoskeleton, Inc.), 
16 µM unlabeled tubulin in BRB80 (80 mM Pipes-KOH, pH 6.9, 1 mM 
MgCl2, and 1 mM EGTA), and 1 mM Mg-GMPCPP (Jena Bioscience) were 
incubated for 30 min at 37°C and pelleted for 10 min at 80,000 rpm in 
a TLA-100 rotor. The microtubule seeds were resuspended in 7.2 µl of ice-
cold BRB80 and incubated on ice for 20 min to promote disassembly. The 
once-cycled tubulin was then supplemented with 1 mM GMP-CPP, incu-
bated for 30 min at 30°C, and pelleted. The double-cycled microtubule 
seeds were resuspended in 100 µl BRB80 and stored in the dark at 37°C. 
Imaging chambers were prepared using silanized coverslips separated by 
double-sided tape (Gell et al., 2010). To immobilize biotinylated micro-
tubule seeds, imaging chambers were first incubated with 50 µg/ml Neu-
travidin (Thermo Fisher Scientific) at room temperature for 5 min followed 
by 1% (vol/vol) Pluronic F127 (Sigma-Aldrich) at room temperature for 
5 min. Biotinylated, GMPCPP-stabilized microtubule seeds were then bound 
to the imaging chambers by flowing the microtubule seeds through the 
chambers and incubating for 15 min at 37°C. KIF4A was phosphorylated 
in vitro by incubating 445 nM KIF4A with 55 nM Baronase and 1 mM ATP 
for 30 min at 30°C. For experiments where the effect of KIF4A was studied 
to compare with phosphorylated KIF4, 445 nM of KIF4A was incubated 
with 1 mM ATP for 30 min at 30°C in the absence of Baronase. Micro-
tubule growth was initiated by flowing in tubulin reaction mixture containing 
17.5 µM unlabeled tubulin, 1 mM GTP, 1 mM ATP, and 14 nM mCherry-PRC1 
to fill the chamber. KIF4A or in vitro–phosphorylated KIF4A was added to 
the tubulin reaction mixture to study its effect on microtubule overlaps as 
defined in the figure legends. The imaging chambers were sealed with nail 
polish and immediately placed on the spinning disk confocal microscope 
for imaging. Imaging was performed at 37°C using an inverted micro-
scope (IX81; Olympus) with a 60×/1.42 NA oil immersion objective cou-
pled to a spinning disk confocal system (Ultraview Vox; PerkinElmer) fitted 
with an EM-CCD camera (C9100-13; Hamamatsu Photonics). The tem-
perature of the objective was maintained at 37°C throughout the exper-
iment. Exposure times were 30 ms for HiLyte-488 tubulin and mCherry-PRC1 
using 4% laser power. The images were taken every 10 s for 20 min. The 
ability of PRC1-Baronase to form anti-parallel microtubule overlaps was stud-
ied by replacing mCherry-PRC1 with mCherry-PRC1-Baronase in the tubu-
lin reaction mixture in the absence and presence of 10 µM ZM447439.
Single-microtubule polymerization assay
Flow chambers were prepared as for the dynamic microtubule overlap assay. 
The tubulin reaction mixture was prepared using 15.75 µM tubulin, 1.75 µM 
Hilyte-488 tubulin, 1 mM GTP, 1 mM ATP, anti-blinking cocktail (500 nM 
glucose oxidase, 64 nM catalase, 40 mM d-glucose, 1% [vol/vol] -mercap-
toethanol), and 0.1% methyl cellulose (4000 cP, Sigma-Aldrich). KIF4A or 
in vitro–phosphorylated KIF4A at the concentrations defined in the figure leg-
ends were added to the tubulin reaction mixture to study their effects on micro-
tubule dynamics. Imaging chambers were filled with tubulin reaction mixture 
and then sealed with nail polish. TIRF imaging was performed at 30°C with a 
super resolution microscope (OMX V3; Applied Precision) using the 60×/1.49 
NA oil immersion objective and an sCMOS camera (PCO AG). The im-
ages were taken using a 488-nm laser and the 10% neutral density filter 
every 3 s for 10 min with a 50-ms exposure time.
Online supplemental material
Fig. S1 shows additional characterization of the eGFP-PRC1 and KIF4A 
stable cell lines. Fig. S2 confirms the specificity of the KIF4A pT799 anti-
body. Figs. S3 and S4 show the effects of KIF4A and MCAK with and with-
out Aurora B phosphorylation on microtubule binding and microtubule 
destabilization. Fig. S5 describes the characterization of the Baronase mod-
ule. Online supplemental material is available at http://www.jcb.org/cgi/ 
content/full/jcb.201301094/DC1. Additional data are available in the 
JCB DataViewer at http://dx.doi.org/10.1083/jcb.201301094.dv.
were acquired for 60 time points every second and then a further 60 time 
points every 2 s. Quantification and analysis of the FRAP data were per-
formed using the Volocity FRAP plug-in. Images in 24-bit RGB TIFF format 
were then placed into Adobe Illustrator CS3 to produce the figures.
Microtubule polymerization assays
Standard microtubule polymerization assays were performed using porcine 
tubulin and a commercial fluorescence-based assay system (Cytoskeleton, 
Inc.). Porcine tubulin stock solution was in GTB (80 mM Pipes, pH 6.9, 2 mM 
MgCl2, and 0.5 mM EGTA). A tubulin master mix was created on ice from 
243 µl of BP01 (80 mM Pipes-KOH, pH 6.9, 2 mM MgCl2, 0.5 mM EGTA, 
and 10 µM 4’,6-diamidino-2-phenylindole), 112 µl of TGB (80 mM Pipes-
KOH, pH 6.9, 2 mM MgCl2, 0.5 mM EGTA, and 60% [vol/vol] glycerol), 
85 µl of 10 mg/ml porcine tubulin, 4.44 µl of 100 mM GTP, and 4.44 µl of 
100 mM ATP. Reactions were set up in 96-well plates by mixing the protein 
in a total volume of 7.5 µl TND on ice. Proteins were tested in the range of 
50–500 nM final assay concentration. To start the assay, 50 µl of tubulin 
master mix was added to each well while on ice, to give a total assay volume 
of 57.5 µl. Final assay composition was: 80 mM Pipes-KOH, pH 6.9, 39 mM 
NaCl, 2 mM MgCl2, 0.5 mM EGTA, 0.87 mM GTP, 0.87 mM ATP, 13% 
(vol/vol) glycerol, and 2.2 µM 4’,6-diamidino-2-phenylindole. This was then 
rapidly transferred to a plate reader (Tristar LB 941; Berthold Technologies) set 
to 340 nm excitation and 420 nm emission, and 37°C. Readings were ac-
quired every minute for one hour. Because reactions were pipetted on ice, 
condensation on the plates formed as they were transferred into the plate 
reader and interfered with the measurements. After an initial period of equili-
bration after which the plate comes to the set temperature and this condensa-
tion clears (defined as t = 0 min), values were plotted as a function of time.
Microtubule pelleting assays
Taxol-stabilized microtubules were produced by incubating 45 µl 7.4 mg/ml 
porcine tubulin, 4.5 µl TGB, and 0.55 µl 100 mM GTP at 37°C for 20 min. 
To stabilize the microtubules, 8 µl of 2 mM paclitaxel in 750 µl GTB was 
added to the microtubule polymerization reaction. This tubulin stock mix 
(3.75 µM) was stored at room temperature until further use. Proteins to be 
tested were diluted in GTB to give the final concentrations defined in the 
figure legends. For experiments involving titration, 3.125–100 nM of ei-
ther KIF4A or KIF4A prephosphorylated by Aurora B was incubated with 
175 nM polymerized tubulin to give a final volume of 80 µl 80 mM Pipes-
KOH, pH 6.9, 2 mM MgCl2, 0.5 mM EGTA, and 20 µM paclitaxel. Sam-
ples were centrifuged for 10 min at 80,000 rpm in a TLA-100 rotor. The 
supernatant was removed and mixed with 20 µl 5× SDS-PAGE sample buf-
fer. The pellet was resuspended in 100 µl of 1× SDS-PAGE sample buffer. 
Equal amounts of both supernatant and pellet fractions were analyzed by 
SDS-PAGE and Western blotting.
Microtubule destabilization assays
Taxol-stabilized microtubules were produced by incubating 45 µl 7.4 mg/ml 
porcine tubulin, 4.5 µl TGB, and 0.55 µl 100 mM GTP at 37°C for 20 min. 
To stabilize the microtubules, 8 µl of 2 mM paclitaxel in 750 µl GTB was 
added to the microtubule polymerization reaction. This 3.75 µM tubulin 
stock mix was stored at room temperature until further use. An 80-µl reac-
tion mixture was assembled containing 1.4 µM polymerized microtubules, 
25 µg/ml BSA, 250 nM MCAK, or 200 nM KIF4A full-length proteins or 
motor domains. For some reactions MCAK and KIF4A were prephosphory-
lated using Aurora B. Final buffer composition was 80 mM Pipes, pH 6.9, 
2 mM MgCl2, 0.5 mM EGTA, and 9 µM paclitaxel. The reaction mix was 
incubated in the absence or presence of 1 mM ATP added from a 100-mM 
stock for 20 min at 37°C. Samples were centrifuged and analyzed as 
described for microtubule pelleting assays.
Kinesin motor ATPase assays
A commercial enzyme–linked inorganic phosphate assay was used to 
measure kinesin ATPase activity (Cytoskeleton, Inc.). In brief, a microtubule 
premix was created at room temperature by mixing 1 ml of reaction buffer 
(15 mM Pipes-KOH, pH 7, and 5 mM MgCl2), 10 µl of 2 mM paclitaxel, 
80 µl of preassembled microtubules (1 mg/ml tubulin, 15 mM Pipes-KOH, 
pH 7, 5 mM MgCl2, 1 mM GTP, and 20 µM paclitaxel), 240 µl of 1 mM 
2-amino-6-mercapto-7-methylpurine riboside, and 12 µl of 0.1 U/µl purine 
nucleoside phosphorylase. Phosphorylated KIF4FL or KIF4MD were prepared 
by preincubating the motor protein with 10 nM of either wild-type Aurora 
kinase or the inactive “kinase-dead” mutant in a final volume of 7.5 µl TND 
containing 1 mM Mg-ATP for 30 min at 30°C. Reactions were set up in 
96-well plates by mixing the protein of interest in a total volume of 7.5 µl 
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